Related Experiment Video

Updated: Jun 11, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

AMP-activated kinase (AMPK)-generated signals in malignant melanoma cell growth and survival

Jennifer Woodard1, Leonidas C Platanias

  • 1Robert H. Lurie Comprehensive Cancer Center, Division of Hematology-Oncology, Northwestern University, Medical School, Jesse Brown VA Medical Center, Chicago, IL 60611, USA.

Biochemical and Biophysical Research Communications
|July 6, 2010
PubMed

Insights

AMP-activated kinase (AMPK) inhibits malignant melanoma growth and survival. Activating AMPK with AICAR or metformin suppressed tumor cell proliferation and colony formation, offering a potential new treatment strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • AMP-activated kinase (AMPK) is known to negatively regulate the mammalian target of rapamycin (mTOR) signaling pathway.
  • The role of AMPK in the regulation of malignant melanoma cell growth and survival remains to be fully elucidated.

Purpose of the Study:

  • To investigate the involvement of AMPK in the control of malignant melanoma cell proliferation and survival.
  • To explore the therapeutic potential of targeting the AMPK pathway in melanoma treatment.

Main Methods:

  • Utilized AMPK activators AICAR and metformin on SK-MEL-2 and SK-MEL-28 malignant melanoma cell lines.
  • Assessed melanoma cell growth, anchorage-independent colony formation in soft agar, and apoptosis induction.
  • Investigated the combined effects of AICAR and statin treatment on melanoma cell apoptosis.

Main Results:

  • AMPK activation by AICAR or metformin significantly inhibited the growth of malignant melanoma cells.
  • AMPK activation reduced the ability of melanoma cells to form colonies in soft agar, indicating an impact on tumorigenesis.
  • AICAR treatment induced melanoma cell death, with apoptosis further enhanced by co-treatment with statins.

Conclusions:

  • AMPK activation demonstrates potent inhibitory effects on malignant melanoma cell growth and survival.
  • Targeting AMPK represents a promising novel therapeutic strategy for the treatment of malignant melanoma.
  • The findings support further research into AMPK-modulating agents for melanoma therapy.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...